Centogene logo

Centogene

Stock
Stock
ISIN: NL0014040206
Ticker: CNTG
NL0014040206
CNTG

Price

Price

CHART BY

Frequently asked questions

What is Centogene's market capitalization?

The market capitalization of Centogene is $3.86M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for Centogene?

Centogene's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$1.404. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Centogene's stock?

Currently, 1 analysts cover Centogene's stock, with a consensus target price of $1.536. Analyst ratings provide insights into the stock's expected performance.

What is Centogene's revenue over the trailing twelve months?

Over the trailing twelve months, Centogene reported a revenue of $53.74M.

What is the EBITDA for Centogene?

Centogene's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$37.05M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Centogene?

Centogene has a free cash flow of -$41.85M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

How many employees does Centogene have, and what sector and industry does it belong to?

Centogene employs approximately 493 people. It operates in the Health Care sector, specifically within the Miscellaneous Commercial Services industry.

What is the free float of Centogene's shares?

The free float of Centogene is 11.76M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$3.86M
EPS (TTM) 
-$1.404
Free Float 
11.76M
Revenue (TTM) 
$53.74M
EBITDA (TTM) 
-$37.05M
Free Cashflow (TTM) 
-$41.85M

Pricing

52W span
$0.0376$1.25

Analyst Ratings

The price target is $1.536 and the stock is covered by 1 analysts.

Buy

1

Hold

0

Sell

0

Information

Centogene NV is a commercial-stage company, which focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. It operates through the following segments: Pharmaceutical, Diagnostics, and Corporate. The Pharmaceutical segment provides solutions to pharmaceutical partners, including target discovery, early patient recruitment and identification, epidemiological insights, and biomarker discovery. The Diagnostics segment offers genetic sequencing and diagnostics services to clients, who are typically physicians, laboratories, or hospitals, either directly or through distributors. The Other segment covers COVID-19 testing services to clients. The company was founded by Arndt Rolf and Christoph Ehlers in 2006 and is headquartered in Rostock, Denmark.

Employees
493
Industries
Miscellaneous Commercial Services
Sector
Health Care

Identifier

ISIN
NL0014040206
Primary Ticker
CNTG
Join the conversation